Post COVID-19 mucormycosis in critical care settings: A prospective cohort study in a tertiary care center in Egypt
Identifying high-risk patients especially old diabetic patients with corticosteroid administration and detecting their deterioration quickly is crucial in reducing post-COVID-19 mucormycosis mortality rates, and these factors must be considered when developing treatment and quarantine strategies.
Authors
- Ayman M. E. M. Sadek (ORCID: https://orcid.org/0000-0002-1095-1411)
- Dina Sameh Elrafey
- Hossam Tharwat Ali (ORCID: https://orcid.org/0000-0001-8077-5911)
- Hanaa A. Nofal (ORCID: https://orcid.org/0000-0002-5909-4238)
- Nevin F. Ibrahim (ORCID: https://orcid.org/0000-0002-1007-2812)
- Nahawand A. El- Deeb (ORCID: https://orcid.org/0009-0009-2570-8578)
- Shaherah Yousef Andargeery
- Ebthall Mohamed
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- South Valley University (EG)
- Zagazig University (EG)
Publication Details
- Journal
- Journal of Infection and Public Health
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.jiph.2024.102523
- Citations
- 2
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.78
Funders
- Princess Nourah Bint Abdulrahman University